Skip to main content
. Author manuscript; available in PMC: 2018 Jan 24.
Published in final edited form as: Mol Cancer Ther. 2017 Mar 14;16(6):1102–1113. doi: 10.1158/1535-7163.MCT-16-0314

Figure 2.

Figure 2

A low Fas ligand (FasL)/Fas ratio promotes tumor growth of OSCC in vitro and in vivo. A and B, qPCR Analysis of FASLG (A) and FAS (B). C, In vitro cell proliferation indexes of the OSCC lines were determined with the IncuCyte Life-Cell Imaging System. D, Correlation between the FasL/Fas ratio and cell proliferation rate in OSCC cells. Spearman correlation coefficient = 0.863; P = 0.078. E, Tumor growth rates of the OSCC lines in vivo. Each of the OSCC lines were subcutaneously implanted into mice (n = 5). Tumor volume of each of the OSCC lines was monitored weekly. Data were presented as mean ± SE and subjected to one-way ANOVA with Tukey post hoc tests to analyze the statistical significances. The symbol "***" represents P < 0.001.